Home Healthcare Pharmaceuticals Topical Pain Relief Market

Topical Pain Relief Market Size, Share & Trends Analysis Report By Drug Class (Opioids, Non-opioids), By Formulation (Creams and Ointments, Gels, Sprays, Patch, Others), By Type (Prescription Based, Over-the-counter (OTC)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Dhanashri Chandgude | Format:

Topical Pain Relief Market Size

The global topical pain relief market size was valued at USD 12.51 billion in 2025 and is projected to grow from USD 13.25 billion in 2026 to USD 20.96 billion by 2034, registering a CAGR of 5.9% during the forecast period from 2026 to 2034. North America dominated the topical pain relief market with a market share of 38.4% in 2025.

The topical pain relief market involves the development, manufacture and distribution of medicated products that are applied directly to the skin to relieve pain and discomfort. These medications target localized muscle, joint, and nerve pain and offer a non-invasive and often safer alternative to oral pain relievers. There is a wide variety of formulations in the market, including creams, gels, sprays and patches, each tailored to specific needs and preferences. The market's focus on convenience, non-invasive use and its adaptation to the growing need for safer pain relief allows for significant expansion.

The topical pain relief market is fuelled by several factors: an aging population with an increase in chronic pain problems such as arthritis, awareness of opioid risks leading to a search for safer pain relief options, and increased participation in sports and outdoor activities that can lead to muscle and joint pain. This demand for convenient and non-addictive pain relief is driving the market for topical creams, gels and patches.

Topical Pain Relief Market Size

Download a Free Sample To learn more about this report.

Drug Class Analysis

The market is segmented into opioids and non-opioids. Non-opioids dominate the drug class segment. Since non-opioid medications are more widely available and often sold without a prescription, mild to moderate pain can be easily self-treated. In addition, they generally have a safer profile than opioids, mitigating concerns about addiction and broader systemic effects. Based on application, the market is segmented into home and dentistry.

Topical Pain Relief Market Size By Segments

Request Customizationto receive a tailored report.

Formulation Analysis

The market is segmented into creams and ointments, gels, sprays, patches, and others. Creams and ointments dominate the formulation segment. Creams are adaptable, accommodating different kinds of pain and varying dosages of medicine. Additionally, they are might be slightly better at absorbing the ingredients, which could result in a greater soothing impact.

Type Analysis

The market is segmented into prescription based and over-the-counter (OTC). Over-the-counter (OTC) dominate the type segment. Easy access makes it possible to quickly treat mild discomfort without consulting a doctor. Furthermore, they are better suited for a wider range of consumers because to their typically milder side effect profile as compared to prescription alternatives. OTC dominates the topical pain relief market due to its strong safety profile and convenient nature.

distribution Channel Analysis

The market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. Retail pharmacies dominate the distribution channel segment. This is because they are widely available and convenient to consumers seeking immediate relief. Online pharmacies, on the other hand, are expanding rapidly and might eventually challenge traditional retail's dominance with their convenient and possibly affordable prices.

Topical Pain Relief Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

Based on region, the global topical pain relief market share is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North America Dominates the Global Market

North America is the most significant global market shareholder and is expected to expand substantially during the forecast period. North America leads the topical pain reliever market due to a perfect storm: high prevalence of chronic pain, strong healthcare systems that drive diagnosis and treatment with topical options, strong research and development by key major pharmaceutical players.

U.S. topical pain relief market. Chronic pain drives the U.S. topical pain relief market. Easy access to healthcare professionals and over-the-counter options, along with strong R&D by major pharma companies, solidify U.S. dominance.

Canada topical pain relief market. Canada’s well-developed healthcare system facilitates diagnosis and treatment with topical options and rising awareness of topical pain relief benefits and easy access to over-the-counter medications solidify Canada's market strength.

Thus, the factors above are estimated to boost the North America topical pain relief market growth.

Asia-Pacific region is a pivotal market for the arthroscopic shaver industry. Pain relief options are becoming more affordable, increasing accessibility for a wider Indian consumer base. Additionally, a preference for natural products is on the rise in India, and many topical pain relievers are formulated with natural ingredients like menthol and turmeric, further propelling topical pain relief market growth.

The China topical pain relief market. Rising disposable income fuels spending on healthcare products like topical pain relievers. Investments in domestic production further strengthens China's position in the Asia Pacific market.

The India topical pain relief market. Rising disposable income among a growing middle class, and a growing prevalence of dental problems caused by sugary diets and lifestyle choices are contributing to the country’s market growth.

These factors are estimated to drive the Asia Pacific topical pain relief market growth.

North America Topical Pain Relief Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

List of Key and Emerging Players in Topical Pain Relief Market

Johnson & Johnson
Glaxosmithkline Plc (GSK)
Sanofi
Bayer AG
Abbott
Reckitt Benckiser Group Plc.
Teva Pharmaceutical Industries Ltd.
Haleon Group of Companies
Procter & Gamble
Sun Pharmaceutical Industries Ltd.
Amneal Pharmaceuticals LLC.
Hisamitsu Pharmaceutical Co., Inc.
Mallinckrodt Pharmaceuticals

Key Industry Developments

July 2025
Haleon reported the continued rollout of Voltaren 24-hour Pain Relief Patch into additional European markets, including Portugal, Austria, and the UK, while introducing new patch formats and expanding systemic Voltadexibu in Germany and Italy to strengthen its pain management portfolio.
May 2025
Haleon expanded its topical pain relief portfolio by launching Voltaren 2% in China, targeting older adults with a long-lasting anti-inflammatory formulation, supporting the company's geographic expansion strategy in the pain relief segment.
May 2025
Haleon strengthened the Voltaren brand by activating its partnership as the official licensed pain relief brand of the UEFA Champions League, increasing brand visibility through in-store promotions and experiential marketing during the tournament final in Munich.

Report Scope

Segmentation

By Drug Class 2
  • Opioids
  • Non-opioids
By Formulation 5
  • Creams and Ointments
  • Gels
  • Sprays
  • Patch
  • Others
By Type 2
  • Prescription Based
  • Over-the-counter (OTC)
By Distribution Channel 3
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 8
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Singapore
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Johnson & Johnson · Glaxosmithkline Plc (GSK) · Sanofi · Bayer AG · Abbott
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The topical pain relief market size is valued at USD 13.25 Billion in 2026 and is projected to reach USD 20.96 Billion by 2034, at a CAGR of 5.9% during the forecast period 2026-2034.

North America dominated the market with a share of 38.4% in 2025.

The leading players in this market are Johnson & Johnson, Glaxosmithkline Plc, Sanofi, Bayer AG, Abbott.

The topical pain relief market is projected to grow at a CAGR of 5.9% during the forecast period of 2026 2034.
About the Author
Dhanashri Chandgude
Dhanashri Chandgude
Senior Research Associate

Dhanashri Chandgude is a healthcare research professional with over four years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.

Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: